Maroto Vela M C, Bernal Zamora M C, Levya Garcia A, Piédrola G
Infection. 1986 Jul-Aug;14(4):159-62. doi: 10.1007/BF01645254.
A study has been carried out on the sera of 710 women who wished to know their state of rubella immunity using haemagglutination inhibition (HAI) and enzyme-linked immunoassay (ELISA) techniques. The majority of the women presented no symptoms. The ability of HAI to detect low antibody levels (1:8, 1:16) appears to be greater than that of Rubazyme ELISA IgG, employing the recommendations of the manufacturers. The correlation between HAI and IgG values above HAI titres of 1:16 is nearly 100%. In an additional study of 17 primary infections in pregnant women with definite rubella symptoms, the total titre of antibodies was determined by HAI and IgG and specific IgM with ELISA Rubazyme in successive samples. In four cases, IgM was clearly positive and no increase in either HAI or IgG antibodies could be demonstrated over three successive samples taken at an interval of 15 to 20 days. Therefore, we consider it necessary to determine IgM antibodies (evaluating these in the absence of the rheumatoid factor) in every doubtful case occurring in pregnant women, irrespective of whether clinical signs are present or not.
对710名希望了解自身风疹免疫状态的女性血清进行了一项研究,采用血凝抑制(HAI)和酶联免疫吸附测定(ELISA)技术。大多数女性没有症状。按照制造商的建议,HAI检测低抗体水平(1:8、1:16)的能力似乎比Rubazyme ELISA IgG更强。HAI与HAI滴度高于1:16时的IgG值之间的相关性接近100%。在另一项针对17例有明确风疹症状的孕妇原发性感染的研究中,通过HAI和IgG以及ELISA Rubazyme对连续样本中的特异性IgM测定抗体总滴度。在4例中,IgM明显呈阳性,并且在间隔15至20天采集的连续3个样本中,HAI或IgG抗体均未显示增加。因此,我们认为有必要在孕妇出现的每一例可疑病例中测定IgM抗体(在不存在类风湿因子的情况下进行评估),无论是否存在临床体征。